Radioimmunoassay for saralasin by means of anti-angiotensin II sera.
A radioimmunoassay for the angiotensin II-inhibitor saralasin has been developed. The assay is based upon an exploitation of the cross-reactivity of antisera raised against angiotensin II, with radioiodinated saralasin as the tracer peptide. Performance data for the assay and results obtained in clinical infusion studies are presented.
D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000276:immunology; D003429:Cross Reactions; D006801:Humans; D006973:Hypertension / Q000097:blood; D007106:Immune Sera; D007263:Infusions, Parenteral; D011863:Radioimmunoassay / Q000379:methods; D012504:Saralasin / Q000008:administration & dosage / Q000097:blood*
D007106:Immune Sera; D000804:Angiotensin II; D012504:Saralasin